Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -987 | N/A | -987 | N/A | -1,296 |
| Depreciation Amortization | 319 | N/A | 319 | N/A | 177 |
| Other Working Capital | 23 | N/A | 23 | N/A | 42 |
| Other Operating Activity | -6 | 0 | -6 | 0 | 116 |
| Operating Cash Flow | $-651 | $N/A | $-651 | $N/A | $-961 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -144 | N/A | -144 | N/A | -71 |
| Other Investing Activity | 261 | 0 | 261 | 0 | -133 |
| Investing Cash Flow | $117 | $N/A | $117 | $N/A | $-204 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 13 | N/A | 13 | N/A | N/A |
| Other Financing Activity | 881 | 0 | 881 | 0 | 92 |
| Financing Cash Flow | $893 | $N/A | $893 | $N/A | $92 |
| Beginning Cash Position | 694 | N/A | 694 | N/A | 1,767 |
| End Cash Position | 1,053 | N/A | 1,053 | N/A | 694 |
| Net Cash Flow | $360 | $N/A | $360 | $N/A | $-1,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -651 | N/A | -651 | N/A | -961 |
| Free Cash Flow | -651 | 0 | -651 | 0 | -961 |